GWAS-based CNV SCAN on human traits

CHR	GWAS_SNP	GWAS_BP	CNV_BP	NPROB	r2CEU	r2YRI	r2CHBJPT	P-VAL	GENES	TRAIT	PMID	FIGURE
1	rs2240335	17674537	17677196	12	0.82	0.65	0.95	2.0e-8	PADI4(1);PADI6(2);RCC2(2)	Rheumatoid arthritis	LINK
1	rs7538876	17722363	17738167	1	0.72	0.59	0.62	4.0e-12	PADI6(1);PADI4(2);RCC2(2)	Basal cell carcinoma	LINK
1	rs527409	58757915	58744163	10	1	0.29	0.13	1.0e-6	DAB1(2)	Kawasaki disease	LINK
1	rs12727131	60084516	60048908	4	0.77	0.07	0.75	3.0e-6	FGGY(1)	Neutrophil count	LINK
1	rs1168029	62969402	62982891	1	1	1	0.96	3.0e-13	DOCK7(1);USP1(2)	Lipid metabolism phenotypes	LINK
1	rs1168013	62996838	62982891	1	1	1	0.96	6.0e-8	DOCK7(1)	Triglycerides	LINK
1	rs2131925	63025942	62982891	1	1	1	0.96	5.0e-41	DOCK7(1);ANGPTL3(2)	Cholesterol, total	LINK
1	rs2131925	63025942	62982891	1	1	1	0.96	3.0e-18	DOCK7(1);ANGPTL3(2)	LDL cholesterol	LINK
1	rs2131925	63025942	62982891	1	1	1	0.96	9.0e-43	DOCK7(1);ANGPTL3(2)	Triglycerides	LINK
1	rs10889353	63118196	63111069	1	0.71	0.26	0.58	4.0e-12	DOCK7(1);ANGPTL3(2)	Cholesterol, total	LINK
1	rs10889353	63118196	63111069	1	0.71	0.26	0.58	8.0e-6	DOCK7(1);ANGPTL3(2)	LDL cholesterol	LINK
1	rs10889353	63118196	63111069	1	0.71	0.26	0.58	3.0e-7	DOCK7(1);ANGPTL3(2)	Triglycerides	LINK
1	rs1892534	66105944	66154414	2	0.48	0.87	0.56	7.0e-21	LEPR(2)	C-reactive protein	LINK
1	rs2568958	72765116	72769429	14	1	1	1	1.0e-11	NEGR1(2)	Body mass index	LINK
1	rs2568958	72765116	72769429	14	1	1	1	2.0e-8	NEGR1(2)	Weight	LINK
1	rs2815752	72812440	72769429	14	1	1	1	2.0e-22	NEGR1(2)	Body mass index	LINK
1	rs3126085	152300817	152246726	2	1	0.68	0.77	6.0e-12	FLG(2);FLG2(2)	Atopic dermatitis	LINK
1	rs3120665	152316590	152280788	1	0.79	0.17	0.24	4.0e-6	FLG(2);FLG2(2)	Personality dimensions	LINK
1	rs4085613	152550018	152557073	46	1	1	0.97	7.0e-30	LCE3E(2);LCE3D(2);LCE3C(2);LCE3B(2);LCE3A(2)	Psoriasis	LINK
1	rs4112788	152551276	152557073	46	1	0.46	0.97	3.0e-10	LCE3E(2);LCE3D(2);LCE3C(2);LCE3B(2);LCE3A(2)	Psoriasis	LINK
1	rs67418890	161540857	161493580	1	0.8	0	0	1.0e-10	FCGR2A(2);HSPA6(2);FCGR3A(2);FCGR2C(2);HSPA7(2)	Lipid metabolism phenotypes	LINK
1	rs16857031	162112910	162116181	1	0.65	0.46	0.86	1.0e-34	NOS1AP(1);MIR4654(2)	QT interval	LINK
1	rs12034383	207803595	207783507	1	0.33	0.52	0.78	2.0e-28	CR1(1);CR1L(2)	Erythrocyte sedimentation rate	LINK
2	rs2947411	614168	630070	9	1	0.71	0.94	2.0e-8	TMEM18(2)	Menarche (age at onset)	LINK
2	rs2867125	622827	623693	8	1	1	0.94	3.0e-49	TMEM18(2)	Body mass index	LINK
2	rs6548238	634905	623693	8	1	1	1	1.0e-18	TMEM18(2)	Body mass index	LINK
2	rs7561317	644953	630070	8	1	0.9	1	4.0e-17	TMEM18(2)	Body mass index	LINK
2	rs7561317	644953	630070	8	1	0.9	1	2.0e-18	TMEM18(2)	Weight	LINK
2	rs7569328	21100778	21121130	1	1	0.14	0	1.0e-7	C2orf43(2)	Coronary heart disease	LINK
2	rs1427407	60718043	60724087	2	0.84	0.79	0.92	6.0e-31	BCL11A(1)	F-cell distribution	LINK
2	rs766432	60719970	60724087	2	1	1	0.89	1.0e-10	BCL11A(1)	Beta thalassemia/hemoglobin E disease	LINK
2	rs11886868	60720246	60724087	1	0.46	0.89	0.02	7.0e-35	BCL11A(1)	Fetal hemoglobin levels	LINK
2	rs6545946	62713533	62716784	1	0.49	0.17	1	7.0e-9	TMEM17(2)	Crohns disease	LINK
2	rs3771166	102986222	102967857	1	1	0.73	0.61	3.0e-9	IL18R1(1);IL1RL1(2);IL18RAP(2)	Asthma	LINK
2	rs17027258	103091540	103087382	1	1	0.91	1	7.0e-6	SLC9A4(1);IL18RAP(2);MIR4772(2)	White blood cell types	LINK
2	rs1402837	169757354	169768750	1	0.74	0.24	0.03	5.0e-10	NOSTRIN(2);SPC25(2);G6PC2(2);ABCB11(2)	Glycated hemoglobin levels	LINK
2	rs563694	169774071	169776139	2	0.94	0.49	0.66	4.0e-7	NOSTRIN(2);SPC25(2);G6PC2(2);ABCB11(2)	Fasting plasma glucose	LINK
2	rs569805	169782880	169776139	2	0.94	0.23	0.66	9.0e-8	ABCB11(1);SPC25(2);G6PC2(2)	Metabolic syndrome (bivariate traits)	LINK
2	rs16856247	169784413	169771519	4	0	0.17	0.87	2.0e-15	ABCB11(1);SPC25(2);G6PC2(2)	Metabolite levels	LINK
2	rs552976	169791438	169776139	5	0.94	0.26	0.32	8.0e-18	ABCB11(1);SPC25(2);G6PC2(2)	Glycated hemoglobin levels	LINK
2	rs1440072	223936738	223947407	3	0.49	0.02	1	4.0e-6	KCNE4(2)	Body mass index	LINK
2	rs1440072	223936738	223947407	3	0.49	0.02	1	8.0e-7	KCNE4(2)	Waist circumference	LINK
3	rs3729931	12626516	12624063	1	0.4	0.8	0.02	7.0e-7	RAF1(1);TSEN2(2);LOC100129480(2);MKRN2(2)	Cardiac hypertrophy	LINK
3	rs3774372	41877414	41833433	2	0.86	0.54	0.73	8.0e-7	ULK4(1)	Blood pressure	LINK
3	rs9815354	41912651	41863353	1	0.4	0.6	0.73	3.0e-9	ULK4(1)	Diastolic blood pressure	LINK
3	rs10510837	60289842	60295081	1	0.37	0.78	0.89	4.0e-6	FHIT(1)	Asperger disorder	LINK
3	rs3772255	156102734	156092703	9	1	0.46	1	8.0e-6	KCNAB1(1)	Aging traits	LINK
3	rs13064954	156854742	156832894	1	0.36	0.01	0.86	7.0e-7	LOC339894(2);LOC100498859(2);CCNL1(2)	Diabetic retinopathy	LINK
3	rs4402960	185511687	185505788	2	1	0.74	0.87	9.0e-16	IGF2BP2(1)	Type 2 diabetes	LINK
3	rs1470579	185529080	185505788	1	1	0.46	0.75	2.0e-7	IGF2BP2(1)	Diabetes (gestational)	LINK
3	rs1470579	185529080	185505788	1	1	0.46	0.75	2.0e-9	IGF2BP2(1)	Type 2 diabetes	LINK
3	rs6769511	185530290	185505788	1	1	0.46	0.75	1.0e-9	IGF2BP2(1)	Type 2 diabetes	LINK
3	rs266717	186530484	186544928	1	0.76	0.35	0.46	9.0e-19	KNG1(2);EIF4A2(2);SNORD2(2);MIR1248(2);SNORA81(2)	Adiponectin levels	LINK
3	rs10937470	191000808	191011464	1	0.54	0.29	0.76	9.0e-6	UTS2D(1);OSTN(2);CCDC50(2)	Total ventricular volume	LINK
4	rs1670533	1078187	1103540	1	0.37	0.01	0.97	2.0e-12	RNF212(1);FGFRL1(2);TMED11P(2)	Recombination rate (females)	LINK
4	rs3796619	1095281	1103540	1	0.62	0.85	0.97	3.0e-24	RNF212(1);TMED11P(2)	Recombination rate (males)	LINK
4	rs6815464	1309901	1290281	3	1	0.38	0.91	2.0e-20	MAEA(1);UVSSA(2)	Type 2 diabetes	LINK
4	rs16890979	9922167	9925526	1	1	1	1	7.0e-168	SLC2A9(1)	Urate levels	LINK
4	rs16890979	9922167	9925526	1	1	1	1	1.0e-11	SLC2A9(1)	Uric acid levels	LINK
4	rs734553	9923004	9925526	1	0.81	0.61	1	1.0e-192	SLC2A9(1)	Uric acid levels	LINK
4	rs13129697	9926967	9921185	2	0.76	0.96	0.69	1.0e-9	SLC2A9(1)	Biochemical measures	LINK
4	rs13129697	9926967	9921185	2	0.76	0.96	0.69	2.0e-242	SLC2A9(1)	Urate levels	LINK
4	rs13129697	9926967	9921185	2	0.76	0.96	0.69	2.0e-19	SLC2A9(1)	Uric acid levels	LINK
4	rs737267	9934744	9925526	1	0.6	0.62	1	3.0e-9	SLC2A9(1)	Urate levels	LINK
4	rs6855911	9935910	9925526	1	0.6	0.62	1	2.0e-16	SLC2A9(1)	Urate levels	LINK
4	rs4481233	9956079	9925526	2	0.82	0.52	1	6.0e-34	SLC2A9(1)	Metabolic traits	LINK
4	rs7442295	9966380	9925526	2	0.82	0.82	1	3.0e-70	SLC2A9(1)	Urate levels	LINK
4	rs3775948	9995182	10000504	2	0.85	0.73	0.65	1.0e-9	SLC2A9(1)	Uric acid levels	LINK
4	rs733175	10050141	10036146	2	1	1	0.98	5.0e-6	SLC2A9(2);WDR1(2);MIR3138(2)	Alzheimers disease	LINK
4	rs6834555	10062326	10040221	2	0.85	0.61	0.9	3.0e-7	SLC2A9(2);WDR1(2);MIR3138(2)	Alzheimers disease	LINK
4	rs3796804	82009707	82054127	1	0.72	0.03	0.64	9.0e-6	BMP3(2);PRKG2(2)	HIV-1 susceptibility	LINK
4	rs1789891	100250419	100268131	1	0.61	0	0.86	1.0e-8	LOC100507053(2);ADH1A(2);ADH1B(2);ADH1C(2)	Alcohol dependence	LINK
4	rs1789891	100250419	100268131	1	0.61	0	0.86	3.0e-6	LOC100507053(2);ADH1A(2);ADH1B(2);ADH1C(2)	Conduct disorder (interaction)	LINK
4	rs4956211	109723126	109721374	4	0.9	0.57	0.72	1.0e-6	AGXT2L1(2);COL25A1(2)	Systemic lupus erythematosus	LINK
4	rs2069762	123377980	123392268	1	0.35	1	0.67	5.0e-7	KIAA1109(2);ADAD1(2);IL2(2)	Type 1 diabetes autoantibodies	LINK
5	rs13361189	150223387	150178347	27	1	1	1	2.0e-10	C5orf62(2);IRGM(2);ZNF300(2)	Crohns disease	LINK
5	rs1000113	150240076	150181492	13	1	0.39	0.91	3.0e-7	IRGM(2);ZNF300(2)	Crohns disease	LINK
5	rs11747270	150258867	150203780	12	1	0.71	1	3.0e-16	IRGM(2);ZNF300(2);ZNF300P1(2)	Crohns disease	LINK
5	rs7714584	150270420	150212972	8	1	0.69	1	8.0e-19	IRGM(2);ZNF300(2);ZNF300P1(2)	Crohns disease	LINK
5	rs2082412	158717789	158723293	1	0.46	0.65	0.85	2.0e-28	RNF145(2);UBLCP1(2);IL12B(2);LOC285626(2)	Psoriasis	LINK
5	rs3213094	158750769	158723293	1	0.46	0.47	0.71	3.0e-26	IL12B(1);UBLCP1(2);LOC285626(2)	Psoriasis	LINK
6	rs872071	411064	432514	1	0.72	0	0.61	2.0e-20	IRF4(1);DUSP22(2);EXOC2(2)	Chronic lymphocytic leukemia	LINK
6	rs1540771	466033	451843	1	0.73	0.03	0.63	4.0e-18	IRF4(2);EXOC2(2)	Freckles	LINK
6	rs10946808	26233387	26207181	1	0.86	1	0.84	4.0e-17	HIST1H2BE(2);HIST1H4D(2);HIST1H3D(2);HIST1H2AD(2)	Height	LINK
6	rs4324798	28776117	28806218	1	0	1	0	2.0e-8	LOC401242(2)	Lung adenocarcinoma	LINK
6	rs9258260	29723161	29696117	3	0.64	0.35	0.97	2.0e-10	HLA-F(2);HLA-F-AS1(2);IFITM4P(2);HCG4(2);LOC554223(2)	Crohns disease	LINK
6	rs1610677	29789171	29819198	3	0.71	0.78	0.78	4.0e-15	HCG4(2);LOC554223(2);HLA-G(2)	Rheumatoid arthritis	LINK
6	rs2523822	29828660	29819198	2	1	0.29	0.95	2.0e-10	HLA-G(2);HLA-H(2)	Drug-induced liver injury	LINK
6	rs2860580	29906691	29857152	1	0.74	0.54	0.4	5.0e-67	HLA-H(2);HCG4B(2);HLA-A(2);HCG9(2)	Nasopharyngeal carcinoma	LINK
6	rs1061235	29913298	29922138	6	1	0.83	0.73	1.0e-7	HLA-A(1);HLA-H(2);HCG4B(2);HCG9(2);ZNRD1-AS1(2)	Adverse response to carbamapezine	LINK
6	rs2517713	29918099	29912410	2	0.76	0.61	0.42	4.0e-20	HLA-H(2);HCG4B(2);HLA-A(2);HCG9(2);ZNRD1-AS1(2)	Nasopharyngeal carcinoma	LINK
6	rs2571391	29923838	29915122	5	1	0.91	0.9	1.0e-15	HCG4B(2);HLA-A(2);HCG9(2);ZNRD1-AS1(2);HLA-J(2)	IgE levels	LINK
6	rs2523946	29941943	29912410	3	0.83	0.31	0.57	2.0e-11	HCG4B(2);HLA-A(2);HCG9(2);ZNRD1-AS1(2);HLA-J(2)	IgA nephropathy	LINK
6	rs6904029	29943067	29942384	5	1	1	0.89	1.0e-21	HCG9(1);HCG4B(2);HLA-A(2);ZNRD1-AS1(2);HLA-J(2)	Vitiligo	LINK
6	rs7758512	29970589	29964999	8	1	0.88	0.9	2.0e-8	ZNRD1-AS1(1);HLA-A(2);HCG9(2);HLA-J(2);ZNRD1(2)	HIV-1 control	LINK
6	rs4313034	29973925	29952069	3	0.24	0.54	0.82	2.0e-15	ZNRD1-AS1(1);HLA-J(1);HCG4B(2);HLA-A(2);HCG9(2)	Graves disease	LINK
6	rs6917603	30017071	29966726	7	1	0.88	0.96	3.0e-29	ZNRD1-AS1(1);HLA-J(2);ZNRD1(2);PPP1R11(2);RNF39(2)	Lipid metabolism phenotypes	LINK
6	rs10947055	30093364	30080956	1	1	0.81	0	2.0e-7	PPP1R11(2);RNF39(2);TRIM31(2);TRIM40(2);TRIM10(2)	Cardiac hypertrophy	LINK
6	rs9468692	30119890	30080956	1	1	0.75	0	1.0e-6	TRIM10(1);TRIM31(2);TRIM40(2);TRIM15(2);TRIM26(2)	HIV-1 control	LINK
6	rs12526186	30736151	30760190	3	0.01	0.8	0.22	3.0e-6	MDC1(2);TUBB(2);FLOT1(2);IER3(2)	Response to antipsychotic treatment	LINK
6	rs4947296	31058178	31080103	1	0.11	0	0.92	4.0e-51	MUC22(2);HCG22(2);C6orf15(2);PSORS1C1(2);CDSN(2)	Graves disease	LINK
6	rs3130573	31106268	31109943	1	0.88	0.02	0.37	6.0e-10	PSORS1C1(1);PSORS1C2(1);C6orf15(2);CDSN(2);CCHCR1(2)	Systemic sclerosis	LINK
6	rs9263739	31111356	31114449	2	1	1	0.79	4.0e-67	CCHCR1(1);C6orf15(2);PSORS1C1(2);CDSN(2);PSORS1C2(2)	Ulcerative colitis	LINK
6	rs1265112	31118019	31109943	1	1	0.94	0.8	1.0e-8	CCHCR1(1);C6orf15(2);PSORS1C1(2);CDSN(2);PSORS1C2(2)	Nevirapine-induced rash	LINK
6	rs13191343	31241109	31255007	4	1	1	0.45	2.0e-72	PSORS1C3(2);HCG27(2);HLA-C(2);HLA-B(2)	Psoriatic arthritis	LINK
6	rs2524054	31252396	31244249	4	0.79	0.72	1	2.0e-28	HLA-C(2)	CD4:CD8 lymphocyte ratio	LINK
6	rs12191877	31252925	31255007	5	1	1	1	1.0e-100	HCG27(2);HLA-C(2);HLA-B(2)	Psoriasis	LINK
6	rs9468925	31258837	31263662	1	0.46	0.74	0.61	2.0e-33	HCG27(2);HLA-C(2);HLA-B(2)	Vitiligo	LINK
6	rs2894207	31263751	31262923	1	0.19	0.82	0.3	3.0e-33	HCG27(2);HLA-C(2);HLA-B(2)	Nasopharyngeal carcinoma	LINK
6	rs2247056	31265490	31244249	4	0.79	0.87	1	2.0e-15	HLA-C(2);HLA-B(2)	Triglycerides	LINK
6	rs9264942	31274380	31238523	1	0.81	0.45	0.54	3.0e-35	HLA-C(2);HLA-B(2)	HIV-1 control	LINK
6	rs10484554	31274555	31255007	5	1	1	0.93	6.0e-8	HLA-C(2);HLA-B(2);MICA(2)	AIDS progression	LINK
6	rs10484554	31274555	31255007	5	1	1	0.93	4.0e-214	HLA-C(2);HLA-B(2);MICA(2)	Psoriasis	LINK
6	rs9378249	31327701	31350464	1	0.72	0	0.44	1.0e-8	HLA-C(2);HLA-B(2);MICA(2)	Bipolar disorder	LINK
6	rs7743761	31336100	31340691	3	0.9	0.93	0.61	5.0e-304	HLA-B(2);MICA(2)	Ankylosing spondylitis	LINK
6	rs1521	31350704	31348322	3	1	0.94	0.95	2.0e-65	HLA-B(2);MICA(2);HCP5(2);HCG26(2)	Graves disease	LINK
6	rs13437082	31354560	31362891	4	1	1	0.97	5.0e-8	HLA-B(2);MICA(2)	Height	LINK
6	rs2596542	31366595	31362891	1	0.82	0.46	0.67	4.0e-13	HLA-B(2);MICA(2)	Hepatocellular carcinoma	LINK
6	rs9469003	31407828	31399821	4	0.89	1	0.89	2.0e-9	HLA-B(2);MICA(2);HCP5(2);HCG26(2);MICB(2)	Stevens-Johnson synd. / toxic epid. necrolysis	LINK
6	rs3099844	31448976	31434334	1	0.77	0.02	0	2.0e-8	HCP5(2);HCG26(2);MICB(2);MCCD1(2);DDX39B(2)	Metabolic syndrome	LINK
6	rs3099844	31448976	31434334	1	0.77	0.02	0	5.0e-10	HCP5(2);HCG26(2);MICB(2);MCCD1(2);DDX39B(2)	Neonatal lupus	LINK
6	rs3130320	32223258	32243088	2	0.4	0.69	0.88	3.0e-6	PPT2(2);PPT2-EGFL8(2);EGFL8(2);AGPAT1(2);RNF5(2)	Systemic lupus erythematosus	LINK
6	rs3130340	32244627	32243107	2	1	0.73	0.88	1.0e-7	AGPAT1(2);RNF5(2);RNF5P1(2);AGER(2);PBX2(2)	Bone mineral density (spine)	LINK
6	rs2395148	32321554	32316389	1	0.01	0.72	0.28	2.0e-10	C6orf10(1);HCG23(2);BTNL2(2)	Arthritis (juvenile idiopathic)	LINK
6	rs1980493	32363215	32401534	2	0.75	0.43	0.84	5.0e-7	BTNL2(1);C6orf10(2);HCG23(2);HLA-DRA(2)	Anti-cyclic Citrullinated Peptide Antibody	LINK
6	rs9268480	32363844	32347533	2	1	1	0.95	3.0e-6	BTNL2(1);C6orf10(2);HCG23(2);HLA-DRA(2)	Ulcerative colitis	LINK
6	rs10947262	32373312	32373378	2	1	0.91	0.93	5.0e-9	BTNL2(1);C6orf10(2);HCG23(2);HLA-DRA(2)	Knee osteoarthritis	LINK
6	rs3806156	32373698	32347533	1	0.78	0.22	0.12	7.0e-19	BTNL2(1);C6orf10(2);HCG23(2);HLA-DRA(2)	Vitiligo	LINK
6	rs2395163	32387809	32347533	2	0.93	0.38	0.8	3.0e-11	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Parkinsons disease	LINK
6	rs3135363	32389648	32383249	1	0.71	0.4	0.22	7.0e-22	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2)	Hepatitis B vaccine response	LINK
6	rs3177928	32412435	32425049	1	0.73	0.73	0.76	4.0e-19	HLA-DRA(1);C6orf10(2);HCG23(2);BTNL2(2);HLA-DRB5(2)	Cholesterol, total	LINK
6	rs3177928	32412435	32425049	1	0.73	0.73	0.76	2.0e-15	HLA-DRA(1);C6orf10(2);HCG23(2);BTNL2(2);HLA-DRB5(2)	LDL cholesterol	LINK
6	rs3135388	32413051	32431543	28	1	0.02	0	4.0e-225	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Multiple sclerosis	LINK
6	rs2227139	32413459	32414290	1	0.86	0.7	0.76	1.0e-7	HCG23(2);BTNL2(2);HLA-DRA(2)	Hematological parameters	LINK
6	rs3129889	32413545	32431543	28	1	0.02	0	1.0e-206	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Multiple sclerosis	LINK
6	rs3129890	32414273	32432373	5	0.73	0.82	0.76	5.0e-13	HCG23(2);BTNL2(2);HLA-DRA(2)	Asthma	LINK
6	rs6903608	32428285	32441392	2	0.73	0.91	0.74	3.0e-50	BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Hodgkins lymphoma	LINK
6	rs9268853	32429643	32434844	3	0.92	1	0.92	5.0e-109	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Rheumatoid arthritis	LINK
6	rs9268853	32429643	32434844	3	0.92	1	0.92	1.0e-55	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Ulcerative colitis	LINK
6	rs9268877	32431147	32441392	1	0.95	0.95	0.94	4.0e-23	BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Ulcerative colitis	LINK
6	rs9268905	32432077	32434844	4	1	1	0.92	1.0e-7	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Cystic fibrosis severity	LINK
6	rs9268923	32432835	32434844	4	1	1	0.92	4.0e-15	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Ulcerative colitis	LINK
6	rs2395185	32433167	32434844	4	1	1	0.92	4.0e-31	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Hodgkins lymphoma	LINK
6	rs2395185	32433167	32434844	4	1	1	0.92	5.0e-22	C6orf10(2);HCG23(2);BTNL2(2);HLA-DRA(2);HLA-DRB5(2)	Ulcerative colitis	LINK
6	rs477515	32569691	32585967	3	0.17	0.88	0.22	1.0e-8	HLA-DRB5(2);HLA-DRB6(2);HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Inflammatory bowel disease	LINK
6	rs9271100	32576478	32559753	16	1	1	1	1.0e-12	HLA-DRB6(2);HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Systemic lupus erythematosus	LINK
6	rs9271366	32586854	32549935	6	0.81	1	0.92	3.0e-33	HLA-DRB6(2);HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Immunoglobulin A	LINK
6	rs9271366	32586854	32549935	6	0.81	1	0.92	2.0e-70	HLA-DRB6(2);HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Inflammatory bowel disease	LINK
6	rs9271366	32586854	32549935	6	0.81	1	0.92	7.0e-184	HLA-DRB6(2);HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Multiple sclerosis	LINK
6	rs28421666	32592737	32595060	2	1	0.71	0.91	2.0e-18	HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Nasopharyngeal carcinoma	LINK
6	rs9272105	32599999	32596036	5	0.91	0.57	0.78	4.0e-10	HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Response to interferon beta therapy	LINK
6	rs9272219	32602269	32601684	2	0.54	0.75	0.61	1.0e-45	HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Rheumatoid arthritis	LINK
6	rs9272219	32602269	32601684	2	0.54	0.75	0.61	7.0e-8	HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Schizophrenia	LINK
6	rs9272346	32604372	32613747	17	0.95	0.88	0.9	5.0e-134	HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2)	Type 1 diabetes	LINK
6	rs7774434	32657578	32668031	2	0.81	0.29	0.37	4.0e-34	HLA-DRB1(2);HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Primary biliary cirrhosis	LINK
6	rs7775228	32658079	32648243	1	0.07	0.94	0.54	5.0e-15	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Asthma	LINK
6	rs7775228	32658079	32648243	1	0.07	0.94	0.54	2.0e-9	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	IgE grass sensitization	LINK
6	rs9469220	32658310	32663442	1	0.43	0.73	0.54	2.0e-6	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Crohns disease	LINK
6	rs2647012	32664458	32663442	6	1	1	1	2.0e-21	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Follicular lymphoma	LINK
6	rs2647012	32664458	32663442	6	1	1	1	8.0e-6	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Systemic lupus erythematosus	LINK
6	rs9357152	32664960	32651005	10	1	0.82	0.81	1.0e-14	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	HPV seropositivity	LINK
6	rs10484561	32665420	32665475	7	1	1	0.85	1.0e-29	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Follicular lymphoma	LINK
6	rs9275390	32669156	32668031	3	0.93	1	0.98	3.0e-54	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Systemic sclerosis	LINK
6	rs2856718	32670255	32679185	10	1	1	0.7	4.0e-37	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Hepatitis B	LINK
6	rs13192471	32671103	32665475	4	0.86	0.73	0.54	2.0e-58	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Rheumatoid arthritis	LINK
6	rs1794275	32671248	32627652	5	0.9	0.69	0.32	3.0e-13	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	IgA nephropathy	LINK
6	rs9275572	32678999	32678206	3	1	0.83	0.95	1.0e-35	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Alopecia areata	LINK
6	rs9275572	32678999	32678206	3	1	0.83	0.95	6.0e-9	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Hepatocellular carcinoma	LINK
6	rs2858331	32681277	32680122	4	0.5	0.47	0.84	1.0e-8	HLA-DQA1(2);HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2);HLA-DOB(2)	IgE levels	LINK
6	rs9275596	32681631	32663442	4	0.93	0.75	0.82	2.0e-26	HLA-DQB1(2);HLA-DQA2(2);HLA-DQB2(2)	Nephropathy	LINK
6	rs2858884	32700083	32706937	1	0.74	0.12	0.69	3.0e-8	HLA-DQA2(2);HLA-DQB2(2)	Narcolepsy	LINK
6	rs2301271	32725193	32704362	3	0.56	0.46	0.73	2.0e-12	HLA-DQB2(1);HLA-DQA2(2);HLA-DOB(2)	Systemic lupus erythematosus	LINK
6	rs7453920	32730012	32693401	1	0.45	0.13	0.88	6.0e-28	HLA-DQB2(1);HLA-DQB1(2);HLA-DQA2(2);HLA-DOB(2);TAP2(2)	Hepatitis B	LINK
6	rs3077	33033022	33030885	3	0.61	0.94	1	2.0e-61	HLA-DPA1(1);HLA-DOA(2);HLA-DPB1(2);HLA-DPB2(2)	Hepatitis B	LINK
6	rs987870	33042880	33083202	4	0.82	0.71	0.22	2.0e-10	HLA-DPA1(1);HLA-DPB1(2);HLA-DPB2(2)	Asthma	LINK
6	rs987870	33042880	33083202	4	0.82	0.71	0.22	2.0e-20	HLA-DPA1(1);HLA-DPB1(2);HLA-DPB2(2)	Systemic sclerosis	LINK
6	rs9277535	33054861	33062016	2	0.66	0.24	0.83	3.0e-54	HLA-DPB1(1);HLA-DPA1(2);HLA-DPB2(2)	Hepatitis B	LINK
6	rs9277535	33054861	33062016	2	0.66	0.24	0.83	3.0e-12	HLA-DPB1(1);HLA-DPA1(2);HLA-DPB2(2)	Hepatitis B vaccine response	LINK
6	rs2281388	33060118	33050369	1	0.48	0	0.93	2.0e-65	HLA-DPA1(2);HLA-DPB1(2);HLA-DPB2(2)	Graves disease	LINK
6	rs210138	33542538	33585127	1	0.77	0.01	0.43	1.0e-13	BAK1(1);GGNBP1(2);LINC00336(2);ITPR3(2)	Testicular germ cell tumor	LINK
6	rs3923809	38440970	38433533	1	0.49	1	0.88	1.0e-17	BTBD9(1)	Restless legs syndrome	LINK
6	rs9296736	53924697	53930407	11	1	1	0.96	3.0e-9	MLIP(1)	Liver enzyme levels (gamma-glutamyl transf)	LINK
6	rs12207601	102355867	102341430	2	1	0	0	2.0e-6	GRIK2(1)	Biochemical measures	LINK
6	rs9322817	105232233	105261989	5	0.44	0.49	0.9	7.0e-6	HACE1(1)	Thyroid stimulating hormone	LINK
6	rs7776054	135418916	135419631	1	0.91	0.94	0.98	7.0e-69	HBS1L(2)	Mean corpuscular hemoglobin	LINK
6	rs9399137	135419018	135419631	1	0.91	0.04	0.98	3.0e-36	HBS1L(2)	F-cell distribution	LINK
6	rs9399137	135419018	135419631	1	0.91	0.04	0.98	1.0e-9	HBS1L(2)	Hematology traits	LINK
6	rs9373124	135423209	135419631	1	0.76	0.17	0.54	7.0e-14	HBS1L(2)	Other erythrocyte phenotypes	LINK
6	rs9373124	135423209	135419631	1	0.76	0.17	0.54	1.0e-10	HBS1L(2)	White blood cell types	LINK
6	rs4895441	135426573	135419631	1	0.83	0.09	0.54	2.0e-9	HBS1L(2)	Hematological and biochemical traits	LINK
6	rs4895441	135426573	135419631	1	0.83	0.09	0.54	7.0e-86	HBS1L(2)	Mean corpuscular volume	LINK
6	rs9376092	135427144	135419631	1	0.76	0.26	0.54	2.0e-11	HBS1L(2)	Beta thalassemia/hemoglobin E disease	LINK
6	rs9402686	135427817	135419631	1	0.83	0.1	0.54	7.0e-42	HBS1L(2)	Hematological parameters	LINK
6	rs9494145	135432552	135419631	1	0.74	0.1	0.47	3.0e-9	HBS1L(2)	Mean platelet volume	LINK
6	rs9494145	135432552	135419631	1	0.74	0.1	0.47	3.0e-15	HBS1L(2)	Red blood cell traits	LINK
6	rs9321490	135494875	135454381	1	0.69	0.3	0.74	2.0e-6	MYB(2)	Multiple sclerosis	LINK
6	rs10499194	138002637	137980243	2	0.92	0.63	0.86	1.0e-9		Rheumatoid arthritis	LINK
6	rs6929137	151936677	151945666	1	0.71	0.01	0.57	2.0e-10	CCDC170(1)	Bone mineral density (spine)	LINK
6	rs2941740	152009638	152042262	2	0.35	0.5	0.92	2.0e-10	ESR1(2)	Bone mineral density (hip)	LINK
6	rs1999805	152068364	152056369	1	0.88	0.01	0.35	2.0e-8	ESR1(1)	Bone mineral density (spine)	LINK
7	rs798544	2763102	2758659	1	0.82	0.66	0.72	7.0e-15	TTYH3(2);AMZ1(2);GNA12(2)	Height	LINK
7	rs798502	2789880	2758659	1	0.74	0.18	0.57	3.0e-15	GNA12(1);AMZ1(2)	Ulcerative colitis	LINK
7	rs798497	2795957	2758659	1	0.68	0.22	0.72	7.0e-7	GNA12(1);AMZ1(2)	Height	LINK
7	rs864745	28180556	28214614	2	0.84	0.1	0.77	5.0e-14	JAZF1(1);JAZF1-AS1(2)	Type 2 diabetes	LINK
7	rs1635852	28189411	28214614	2	0.78	0.1	0.74	9.0e-10	JAZF1(1);JAZF1-AS1(2)	Height	LINK
7	rs849134	28196222	28214614	2	0.84	0.1	0.74	3.0e-9	JAZF1(1);JAZF1-AS1(2)	Type 2 diabetes	LINK
7	rs2075671	100345106	100329189	12	0.87	0	0.91	1.0e-9	ZAN(1);GIGYF1(2);POP7(2);EPO(2);EPHB4(2)	Other erythrocyte phenotypes	LINK
7	rs886774	107495434	107500198	1	1	0.6	0.41	3.0e-8	CBLL1(2);SLC26A3(2);DLD(2);LAMB1(2)	Ulcerative colitis	LINK
7	rs4728142	128573967	128582747	2	0.75	0.83	0.76	8.0e-19	KCP(2);IRF5(2);TNPO3(2)	Systemic lupus erythematosus	LINK
7	rs4728142	128573967	128582747	2	0.75	0.83	0.76	2.0e-8	KCP(2);IRF5(2);TNPO3(2)	Ulcerative colitis	LINK
7	rs12531711	128617466	128663175	2	0.9	0	1	9.0e-17	TNPO3(1);IRF5(2)	Primary biliary cirrhosis	LINK
7	rs12531711	128617466	128663175	2	0.9	0	1	6.0e-9	TNPO3(1);IRF5(2)	Systemic lupus erythematosus	LINK
7	rs12537284	128717906	128663175	3	0.8	0	1	4.0e-19	TNPO3(2);TPI1P2(2);LOC407835(2);TSPAN33(2)	Systemic lupus erythematosus	LINK
7	rs4732038	134250322	134231565	1	0.7	0.45	0.3	1.0e-6	AKR1B15(1);AKR1B10(2)	Longevity	LINK
8	rs1296028	11698747	11703652	1	0.94	0.01	0.04	1.0e-6	NEIL2(2);FDFT1(2);CTSB(2)	Parkinsons disease	LINK
8	rs10958409	55327091	55320947	1	0.04	0.25	0.74	1.0e-10	SOX17(2)	Intracranial aneurysm	LINK
8	rs7833986	57100149	57090642	1	0.78	0.53	0.8	8.0e-10	PLAG1(1);CHCHD7(2)	Height	LINK
8	rs13273123	57100791	57090642	1	0.78	0.03	0.8	1.0e-9	PLAG1(1);CHCHD7(2)	Height	LINK
8	rs4471028	75294975	75316246	1	0.69	0.17	0.74	2.0e-7	JPH1(2);GDAP1(2)	Waist circumference	LINK
8	rs10481151	124831834	124795613	1	0.07	0.4	0.85	4.0e-7	FAM91A1(2);FER1L6(2)	Cognitive performance	LINK
9	rs10974944	5070831	5114523	1	0.79	0.57	0.96	4.0e-20	JAK2(1)	Myeloproliferative neoplasms	LINK
9	rs7023329	21816528	21785142	1	0.49	0.12	0.94	7.0e-9	MTAP(1)	Melanoma	LINK
9	rs10757269	22072264	22115285	1	0.81	0	0.16	9.0e-9	CDKN2B-AS1(1)	Ankle-brachial index	LINK
9	rs10757272	22088260	22115285	1	0.87	0.22	0.4	2.0e-7	CDKN2B-AS1(1)	Intracranial aneurysm	LINK
9	rs4977574	22098574	22115285	2	0.87	0.17	1	2.0e-25	CDKN2B-AS1(1)	Coronary heart disease	LINK
9	rs4977574	22098574	22115285	2	0.87	0.17	1	3.0e-44	CDKN2B-AS1(1)	Myocardial infarction (early onset)	LINK
9	rs10965235	22115105	22115285	1	0	1	0.26	6.0e-12	CDKN2B-AS1(1)	Endometriosis	LINK
9	rs944797	22115286	22115285	2	1	1	1	6.0e-16	CDKN2B-AS1(1)	Coronary heart disease	LINK
9	rs2383207	22115959	22115285	1	1	0	0.38	2.0e-8	CDKN2B-AS1(1)	Abdominal aortic aneurysm	LINK
9	rs10757278	22124477	22121353	2	0.87	0.22	0.92	1.0e-20	CDKN2B-AS1(2)	Myocardial infarction	LINK
9	rs1333049	22125503	22121353	2	0.87	0.28	0.9	3.0e-24	CDKN2B-AS1(2)	Coronary artery calcification	LINK
9	rs1333049	22125503	22121353	2	0.87	0.28	0.9	7.0e-58	CDKN2B-AS1(2)	Coronary heart disease	LINK
9	rs817858	110125811	110114432	1	0.31	0	0.79	7.0e-6	RAD23B(2)	Body mass index	LINK
10	rs2380205	5886734	5892545	2	0.88	0.26	0.9	5.0e-7	FAM208B(2);GDI2(2);ANKRD16(2);FBXO18(2)	Breast cancer	LINK
10	rs1412115	34088053	34096664	1	0.27	0.73	0.49	6.0e-6	LOC100505583(2)	Schizophrenia	LINK
10	rs2742234	43612609	43631699	1	0.76	0.33	0.93	4.0e-18	RET(1);CSGALNACT2(2)	Hirschsprungs disease	LINK
10	rs3123078	51524971	51538166	3	0.94	0.75	0.87	1.0e-19	AGAP7(2);MSMB(2);NCOA4(2)	Prostate cancer	LINK
10	rs10993994	51549496	51543068	3	0.71	0.24	0.84	9.0e-29	MSMB(2);NCOA4(2);TIMM23(2)	Prostate cancer	LINK
10	rs10993994	51549496	51543068	3	0.71	0.24	0.84	7.0e-13	MSMB(2);NCOA4(2);TIMM23(2)	Prostate-specific antigen levels	LINK
10	rs10761482	62085337	62082737	1	0.49	0.14	0.7	8.0e-6	ANK3(1)	Schizophrenia	LINK
10	rs10761731	65027610	65012945	1	0.67	0.83	0.89	2.0e-24	JMJD1C(1)	Platelet counts	LINK
10	rs10761731	65027610	65012945	1	0.67	0.83	0.89	3.0e-12	JMJD1C(1)	Triglycerides	LINK
10	rs17600642	72462994	72449419	3	0.72	1	0.53	5.0e-6	ADAMTS14(1)	Bipolar disorder	LINK
10	rs11185790	91372533	91371445	1	0.74	0.52	0.83	3.0e-7	PANK1(1);MIR107(2)	Metabolic traits	LINK
10	rs10509680	96734339	96720171	1	1	0	0.62	4.0e-7	CYP2C9(1)	Warfarin maintenance dose	LINK
10	rs1057910	96741053	96720171	1	1	0	0.82	3.0e-79	CYP2C9(1);CYP2C8(2)	Warfarin maintenance dose	LINK
10	rs2185570	96751270	96759180	1	0.82	0	0	2.0e-8	CYP2C9(2);CYP2C8(2)	Dehydroepiandrosterone sulphate levels	LINK
10	rs1934951	96798548	96817076	2	0.85	0.61	0.75	1.0e-6	CYP2C8(1);CYP2C9(2)	Osteonecrosis of the jaw	LINK
10	rs2981579	123337335	123353870	2	0.94	0.42	0.67	4.0e-31	FGFR2(1)	Breast cancer	LINK
10	rs2981575	123346116	123353870	2	1	0.77	0.83	1.0e-8	FGFR2(1)	Breast cancer	LINK
10	rs1219648	123346190	123353870	2	1	0.36	0.83	1.0e-30	FGFR2(1)	Breast cancer	LINK
10	rs2981582	123352317	123353870	2	1	0.63	0.57	2.0e-76	FGFR2(1)	Breast cancer	LINK
10	rs10490924	124214448	124217287	10	1	0.94	0.9	0.0e+0	ARMS2(1);PLEKHA1(2);MIR3941(2);HTRA1(2)	Age-related macular degeneration	LINK
10	rs3793917	124219275	124216893	10	1	1	0.95	4.0e-60	PLEKHA1(2);MIR3941(2);ARMS2(2);HTRA1(2)	Age-related macular degeneration	LINK
10	rs11200638	124220544	124216893	10	1	1	0.95	8.0e-12	PLEKHA1(2);MIR3941(2);ARMS2(2);HTRA1(2)	Age-related macular degeneration (wet)	LINK
11	rs17655730	270715	256976	1	0.77	0	0	2.0e-15	RIC8A(2);SIRT3(2);PSMD13(2);NLRP6(2);ATHL1(2)	Mean platelet volume	LINK
11	rs2071348	5264146	5270300	1	0.94	0.02	0.76	3.0e-15	HBBP1(1);OR51V1(2);HBB(2);HBD(2);HBG1(2)	Beta thalassemia/hemoglobin E disease	LINK
11	rs11228719	56440236	56468048	1	0.61	0.33	0.73	4.0e-6	OR8U8(1);OR5M1(2);OR5AP2(2);OR5AR1(2);OR9G1(2)	Orofacial clefts	LINK
11	rs1397048	56466099	56468048	1	0.63	0.67	0.74	7.0e-8	OR8U8(1);OR5AP2(2);OR5AR1(2);OR9G1(2);OR9G9(2)	Hemostatic factors and hematological phenot.	LINK
11	rs2212361	94312323	94322353	1	0.79	0.44	0.92	9.0e-7	PIWIL4(1);LOC643037(2);FUT4(2)	ADHD symptoms	LINK
11	rs3802842	111171709	111139939	1	0.91	0.6	0.97	6.0e-10	C11orf93(1);C11orf53(2);C11orf92(2);MIR4491(2);POU2AF1(2)	Colorectal cancer	LINK
12	rs4363657	21368722	21357750	1	0.2	0.54	0.81	5.0e-8	SLCO1B1(1);SLCO1A2(2)	Bilirubin levels	LINK
12	rs4149081	21378021	21357750	1	0.2	0.54	0.81	3.0e-22	SLCO1B1(1);SLCO1A2(2)	Metabolic traits	LINK
12	rs11175593	40601940	40601941	1	1	0	1	3.0e-10	LRRK2(2)	Crohns disease	LINK
12	rs2638315	56865056	56863770	1	0.09	1	0	2.0e-35	GLS2(1);TIMELESS(2);MIP(2);SPRYD4(2);RBMS2(2)	Metabolite levels	LINK
12	rs2657879	56865338	56863770	1	0.09	1	0	3.0e-17	GLS2(1);TIMELESS(2);MIP(2);SPRYD4(2);RBMS2(2)	Metabolic traits	LINK
12	rs1042725	66358347	66361446	1	0.83	0.81	1	3.0e-20	HMGA2(1)	Height	LINK
12	rs8756	66359752	66361446	1	0.71	0.05	0.36	2.0e-16	HMGA2(1)	Height	LINK
12	rs12424086	66364509	66369772	1	0.51	0	0.88	4.0e-6	HMGA2(2)	number of teeth	LINK
12	rs12424086	66364509	66369772	1	0.51	0	0.88	2.0e-12	HMGA2(2)	Permanent tooth development	LINK
12	rs12424086	66364509	66369772	1	0.51	0	0.88	8.0e-6	HMGA2(2)	time to first tooth eruption	LINK
12	rs7968682	66371880	66361446	1	0.71	0.11	0.34	4.0e-10	HMGA2(2)	Height	LINK
12	rs6489785	121363724	121364323	2	0.9	0.11	1	1.0e-6	SPPL3(2);HNF1A-AS1(2);HNF1A(2)	Longevity	LINK
13	rs16944141	90865546	90864196	12	0.12	0.17	0.9	3.0e-6	MIR622(2)	Prostate cancer (gene x gene interaction)	LINK
13	rs17267292	93323146	93330687	1	1	0.73	0.56	1.0e-7	GPC5(1)	Metabolite levels	LINK
13	rs561241	113760034	113759754	2	0.88	0.15	1	5.0e-16	MCF2L(2);F7(2);F10(2);PROZ(2)	Factor VII	LINK
15	rs3825942	74219582	74223648	1	1	0.65	0.93	3.0e-21	LOC100287616(1);LOXL1(1);TBC1D21(2);STOML1(2)	Glaucoma (exfoliation)	LINK
15	rs893817	74229065	74223623	1	0.52	0.26	0.86	3.0e-6	LOXL1(1);TBC1D21(2);LOC100287616(2);STOML1(2);PML(2)	Aortic root size	LINK
15	rs950776	78926018	78912204	1	0.76	0.01	0.16	4.0e-7	CHRNB4(1);CHRNA5(2);CHRNA3(2)	Sudden cardiac arrest	LINK
15	rs1383484	84522755	84542871	1	0	0	0.71	9.0e-7	ADAMTSL3(1)	Height	LINK
16	rs887864	11158885	11156000	1	0.74	0.26	0.23	1.0e-6	CLEC16A(1)	Allergic rhinitis	LINK
16	rs12708716	11179873	11156000	2	0.79	0.23	0.32	3.0e-18	CLEC16A(1)	Type 1 diabetes	LINK
16	rs12708716	11179873	11156000	2	0.79	0.23	0.32	5.0e-14	CLEC16A(1)	Type 1 diabetes autoantibodies	LINK
16	rs2903692	11238783	11221285	1	0.79	0	0.37	7.0e-11	CLEC16A(1)	Type 1 diabetes	LINK
16	rs6498169	11249329	11267356	1	0.78	0.01	0.41	4.0e-6	CLEC16A(1)	Multiple sclerosis	LINK
16	rs12444979	19933600	19949684	8	1	1	0	3.0e-21	IQCK(2);GPRC5B(2)	Body mass index	LINK
16	rs151222	20674492	20674492	1	0.72	0.49	0.35	6.0e-6	ACSM1(1)	Schizophrenia	LINK
16	rs8049603	23067260	23048341	2	0.47	0.37	0.71	1.0e-6	USP31(2)	Multiple sclerosis	LINK
16	rs11649653	30918487	30881298	1	0.31	0	0.75	3.0e-8	MIR4519(2);BCL7C(2);MIR762(2);CTF1(2);FBXL19-AS1(2)	Triglycerides	LINK
16	rs3925075	31347748	31336717	3	0.52	0.33	0.93	5.0e-6	ITGAM(2);ITGAX(2);ITGAD(2)	IgA nephropathy	LINK
16	rs3104767	52624738	52649308	1	0.89	0.18	0.3	9.0e-19	LOC643714(1);TOX3(2)	Restless legs syndrome	LINK
16	rs3112612	52635164	52649308	1	0.89	0.39	0.28	4.0e-10	LOC643714(1);TOX3(2)	Breast cancer	LINK
17	rs9303277	37976469	38004936	1	0.73	0.09	0.85	2.0e-9	IKZF3(1);ZPBP2(2)	Primary biliary cirrhosis	LINK
17	rs2872507	38040763	38004936	1	0.92	0.15	1	5.0e-9	IKZF3(2);ZPBP2(2);GSDMB(2);ORMDL3(2);LRRC3C(2)	Crohns disease	LINK
17	rs2872507	38040763	38004936	1	0.92	0.15	1	9.0e-7	IKZF3(2);ZPBP2(2);GSDMB(2);ORMDL3(2);LRRC3C(2)	Rheumatoid arthritis	LINK
17	rs2872507	38040763	38004936	1	0.92	0.15	1	2.0e-6	IKZF3(2);ZPBP2(2);GSDMB(2);ORMDL3(2);LRRC3C(2)	Type 1 diabetes autoantibodies	LINK
17	rs2872507	38040763	38004936	1	0.92	0.15	1	5.0e-11	IKZF3(2);ZPBP2(2);GSDMB(2);ORMDL3(2);LRRC3C(2)	Ulcerative colitis	LINK
17	rs8067378	38051348	38004936	1	0.73	0.05	1	1.0e-7	IKZF3(2);ZPBP2(2);GSDMB(2);ORMDL3(2);LRRC3C(2)	Ulcerative colitis	LINK
17	rs17609240	38110689	38114045	1	0.49	0.51	0.8	9.0e-9	IKZF3(2);ZPBP2(2);GSDMB(2);ORMDL3(2);LRRC3C(2)	Hematological parameters	LINK
17	rs11012	43513441	43496468	1	1	0.49	0	6.0e-8	PLEKHM1(1);ARHGAP27(2);MIR4315-2(2);MIR4315-1(2)	Parkinsons disease	LINK
17	rs8070723	44081064	44065741	1	0.75	0.01	0	7.0e-12	MAPT(1);STH(2);KANSL1(2)	Parkinsons disease	LINK
17	rs8070723	44081064	44065741	1	0.75	0.01	0	2.0e-118	MAPT(1);STH(2);KANSL1(2)	Progressive supranuclear palsy	LINK
18	rs17664267	40808798	40832926	1	0.86	0.05	0	7.0e-6	SYT4(2)	Conduct disorder (interaction)	LINK
18	rs12457996	40872273	40832926	1	0.93	0	0	6.0e-6	SYT4(2)	Major depressive disorder	LINK
18	rs17674580	43309911	43336142	1	0.82	0	0.78	8.0e-11	SLC14A1(1);SLC14A2(2)	Bladder cancer	LINK
18	rs7238033	43316966	43336142	1	0.76	0	0.78	9.0e-9	SLC14A1(1);SLC14A2(2)	Bladder cancer	LINK
19	rs7247513	12691185	12694963	13	1	1	0.81	2.0e-6	ZNF490(1);ZNF564(2);ZNF791(2)	Bipolar disorder	LINK
19	rs2637125	48401893	48373386	1	0.35	0	1	3.0e-19	CRX(2);SULT2A1(2);SNAR-A13(2);SNAR-A12(2);SNAR-C1(2)	Dehydroepiandrosterone sulphate levels	LINK
19	rs3936340	48527582	48517536	1	0.67	0.06	0.74	2.0e-6	ELSPBP1(1);BSPH1(2);CABP5(2);PLA2G4C(2)	Intelligence	LINK
19	rs516246	49206172	49207255	1	0.69	0.94	1	8.0e-10	FUT2(1);CA11(2);SEC1(2);NTN5(2);MAMSTR(2)	Liver enzyme levels (gamma-glutamyl transf.)	LINK
19	rs492602	49206417	49207255	1	0.69	0.94	1	2.0e-10	FUT2(1);CA11(2);SEC1(2);NTN5(2);MAMSTR(2)	Cholesterol, total	LINK
19	rs492602	49206417	49207255	1	0.69	0.94	1	5.0e-17	FUT2(1);CA11(2);SEC1(2);NTN5(2);MAMSTR(2)	Vitamin B12 levels	LINK
19	rs602662	49206985	49207255	1	1	0.94	1	3.0e-20	FUT2(1);CA11(2);SEC1(2);NTN5(2);MAMSTR(2)	Folate pathway vitamin levels	LINK
19	rs504963	49208865	49207255	1	0.93	0.37	1	2.0e-8	FUT2(1);CA11(2);SEC1(2);NTN5(2);MAMSTR(2)	Crohns disease	LINK
19	rs503279	49209010	49207255	1	0.93	0.37	1	4.0e-20	FUT2(1);CA11(2);SEC1(2);NTN5(2);MAMSTR(2)	Metabolic traits	LINK
19	rs281379	49214274	49207255	1	0.87	0.03	1	7.0e-12	SEC1(2);NTN5(2);FUT2(2);MAMSTR(2);RASIP1(2)	Crohns disease	LINK
19	rs3865444	51727962	51738920	1	0.8	0	0	2.0e-9	SIGLECP3(2);SIGLEC17P(2);CD33(2);C19orf75(2)	Alzheimers disease (late onset)	LINK
19	rs10411161	52372976	52384061	1	0.75	0.03	0.42	7.0e-6	ZNF577(1);FPR3(2);ZNF649(2);ZNF613(2)	Breast cancer	LINK
19	rs386000	54792761	54805325	1	0.9	0.31	0.49	4.0e-16	LILRA6(2);LILRB5(2);LILRB2(2);MIR4752(2);LILRA3(2)	HDL cholesterol	LINK
20	rs6116492	4698626	4696829	1	1	0.09	0	5.0e-7	PRNP(2);PRND(2);PRNT(2);RASSF2(2)	Creutzfeldt-Jakob disease (variant)	LINK
20	rs867186	33764554	33761837	2	1	0.63	0.74	4.0e-9	PROCR(1);EDEM2(2);MMP24(2)	Anticoagulant levels	LINK
20	rs867186	33764554	33761837	2	1	0.63	0.74	6.0e-37	PROCR(1);EDEM2(2);MMP24(2)	Coagulation factor levels	LINK
20	rs867186	33764554	33761837	2	1	0.63	0.74	4.0e-6	PROCR(1);EDEM2(2);MMP24(2)	D-dimer levels	LINK
20	rs867186	33764554	33761837	2	1	0.63	0.74	2.0e-6	PROCR(1);EDEM2(2);MMP24(2)	Hemostatic factors and hematological phenot.	LINK
20	rs867186	33764554	33761837	2	1	0.63	0.74	2.0e-200	PROCR(1);EDEM2(2);MMP24(2)	Protein C levels	LINK
20	rs6060369	33907161	33950860	1	0.78	0.01	0.09	1.0e-16	UQCC(1);MMP24(2);EIF6(2);FAM83C(2)	Height	LINK
20	rs6088792	33909784	33950860	1	0.94	0.85	0.55	8.0e-7	UQCC(1);MMP24(2);EIF6(2);FAM83C(2)	Height	LINK
20	rs6060373	33914208	33950860	1	0.78	0.01	0.11	2.0e-17	UQCC(1);MMP24(2);EIF6(2);FAM83C(2)	Height	LINK
20	rs6088813	33975181	33950860	2	0.81	0.19	0.32	1.0e-13	UQCC(1);GDF5(2)	Height	LINK
20	rs2236164	34097353	34109715	1	0.73	0.54	0.94	2.0e-6	CEP250(1);C20orf173(2);ERGIC3(2);FER1L4(2)	Height	LINK
20	rs2277862	34152782	34133031	1	1	0.93	1	4.0e-10	FER1L4(1);CEP250(2);C20orf173(2);ERGIC3(2);SPAG4(2)	Cholesterol, total	LINK
22	rs2739330	24295286	24284872	20	0.94	0.69	0.57	2.0e-9	LOC284889(2);MIF(2);GSTT2B(2);GSTT2(2);DDTL(2)	Liver enzyme levels (gamma-glutamyl transf.)	LINK
22	rs4821469	36616445	36613044	9	1	0.47	1	2.0e-19	APOL3(2);APOL4(2);APOL2(2);APOL1(2);MYH9(2)	End-stage renal disease (non-diabetic)	LINK